Tuesday, May 19, 2026 | 5:30 PM-8:00 PM HST
410 Atkinson Dr, Honolulu, HI 96814
Signature Prime Steak and Seafood | 36th Flooor
Fostering Collaboration for Improved Alzheimer’s Disease Management
Gain practical strategies to enhance ARIA detection, management, and team-based care for better patient outcomes
This event is tailored for the interdisciplinary team – neurologists, geriatricians, geriatric psychiatrists, and other professionals caring for patients with Alzheimer’s disease globally.
Participants will gain actionable insights from expert faculty, who will explore:
- Pathophysiologic features contributing to ARIA risk in patients treated with anti-amyloid monoclonal antibodies
- Standardized MRI protocols and grading scales to detect and evaluate ARIA effectively
- Best practices for interdisciplinary communication to enhance coordination and patient safety
Empower your team to tackle the challenges of ARIA management and improve collaboration for AD care!
Meet Our Faculty
Alireza Atri, MD, PhD
Chief Medical Officer, Banner Research
Director, Banner Sun Health Research Institute
Sun City, AZ, USA
In-Person
This activity is tailored for the interdisciplinary team – neurologists, geriatricians, geriatric psychiatrists, and other professionals caring for patients with Alzheimer’s disease globally.
- 5:30–6:00 PM – Arrival
- 6:15 PM – Chapter updates
- 6:30–7:00 PM – Dinner served
- 7:00–8:00 PM – Presentation
- 8:15 PM – Adjourn
After completing this activity, the participant should be better able to:
- Identify pathophysiologic features that put patients taking anti-amyloid monoclonal antibodies at increased risk
for amyloid-related imaging abnormalities (ARIA) - Apply standardized magnetic resonance imaging (MRI) protocols and grading scales to optimally monitor for,
detect, and assess the severity of ARIA in patients receiving anti-amyloid monoclonal antibodies - Integrate best practices for interdisciplinary communication to enhance coordination among radiology, neurology, and geriatrics in the management of ARIA
This activity is provided by MLI
Accreditation, Support and Credit
In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Support Statement
This activity is supported by an educational grant from Lilly.
Medical Learning Institute Inc is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.
Faculty Disclosures
Planner/Presenter
Alireza Atri, MD, PhD
Chief Medical Officer, Banner Research
Director, Banner Sun Health Research Institute
Sun City, AZ, USA
Alireza Atri, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Consultant/Advisor: Eisai, Life Molecular Imaging, Novo Nordisk
Research Support/Grant: ACTC, ADCS, Alzheon, Athira, AZ Alzheimer’s Research Consortium and AZ DHS, ATRI, GAP, Biogen, Biohaven, Eisai, Foundation for NIH (FNIH), Gates Ventures, Indiana University, Johns Hopkins, Lilly, NIA/NIH, USC, Vivoryon, Washington University St. Louis
Other: Royalties or licenses: Oxford University Press / Support for attending meetings and/or travel: Alzheimer’s Association (US), Alzheimer’s Disease International (ADI), American Academy of Neurology (AAN), Michael J Fox Foundation (MJFF)
The following relationships have ended within the last 24 months:
Consultant/Advisor: AriBio (ad hoc), Axsome, Lundbeck, Merck, ONO (ad hoc), Prothena, Vaxxinity
Planner
Maria Vittoria Spampinato, MD has a financial interest/relationship or affiliation in the form of:
Research Funding: Siemens
All of the relevant financial relationships of individuals for this activity have been mitigated.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute Inc, the accredited provider, does not have any relevant financial relationships to disclose with ineligible companies unless listed below.
Disclosure of Unlabeled Use
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity, however, registration is required. In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form and your certificate of credit will be generated. You will receive your certificate from Medical Learning Institute Inc.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
If you have questions regarding your certificate, please contact MLI at mvu@mlieducation.org.
About This Activity
Medical Learning Institute Inc is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute Inc.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute Inc or any of its partners, providers, and/or supporters.
Copyright © 2026 Medical Learning Institute Inc. All Rights Reserved.